Patents
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
06/2008
06/19/2008US20080146604 adenosine receptor antagonists such as 2-(4-Methoxyphenyl)-9-benzylamino-10-cyano-s-triazolo[1,5-a]quinolin, used for treating respiratory system disorders, vision disorders, tumors, allergies or inflammatory disease, ischemia, hypoxia, arrhythmia or urogential disorders
06/19/2008US20080146602 3-Chloro-2-[(2,4-dioxo-1,3-oxazolidin-3-yl)methyl]-5,6,7,8-tetrahydro-4-(4-methoxyphenyl)[1]benzothieno[2,3-b]pyridine-7-carboxamide, salts and prodrugs, used as antiinflammatory agents and for treatment of autoimmune diseases
06/19/2008US20080146594 Thrombopoietin activity modulating compounds and methods
06/19/2008US20080146582 Diazabicyclic Aryl Derivatives and Their Use as Chinolinergic Ligands at the Nicotinic Acetylcholine Receptors
06/19/2008US20080146565 JNK modulators
06/19/2008US20080146563 1,7-Naphthyridines as Pde4 Inhibitors
06/19/2008US20080146561 Certain chemical entities, compositions and methods
06/19/2008US20080146546 Bicyclic and Tricyclic Heteroaromatic Compounds
06/19/2008US20080146539 New carboxylic acid amides, the preparation thereof and their use as medicaments
06/19/2008US20080146535 i.e. (7R)-7-[(Z)-2-(2-amino-5-chlorothiazol-4-yl)-2-(triphenylmethoxyimino]-acetamido]-3-chloro-8-oxo-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylate triethyl amine salt; bacterial infections caused by methicillin-resistant Staphylococcus aureus and various genus Enterococcus bacteria
06/19/2008US20080146458 Process for the preparation of oxazolidinones and method of use thereof
06/19/2008US20080145907 used for immobilization of amine-containing materials such as amino acid, peptide, protein, enzyme, immunoglobulin, DNA, RNA or fragments to substrate surfaces
06/19/2008DE102007012794B3 New pyrido(3,2-h)quinazoline compounds useful to prepare doped organic semi-conductor, which is useful in an organic light-emitting diode, preferably organic solar cells, and modules for an electronic circuits, preferably displays
06/19/2008CA2672367A1 3-h-pyrazolopyridines and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same
06/19/2008CA2672295A1 Aspartyl protease inhibitors containing a tricyclic ring system
06/19/2008CA2672293A1 Aspartyl protease inhibitors
06/19/2008CA2671984A1 New pyridazine derivatives with mch antagonistic activity and medicaments comprising these compounds
06/19/2008CA2671964A1 Indolizine derivatives and the use thereof as antidiabetics
06/19/2008CA2671478A1 Non-nucleoside reverse transcriptase inhibitors
06/19/2008CA2671472A1 Pyrido-pyrazine derivatives useful as herbicidal compounds
06/18/2008EP1932888A1 Labeling dye for biomolecule, labeling kit, and method for detecting biomolecule
06/18/2008EP1932845A1 3-H-pyrazolopyridines and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same
06/18/2008EP1932844A1 Bridged cyclic amine compound and pest control agent
06/18/2008EP1932842A1 Compound having oxadiazole ring structure bonded with aromatic heterocyclic ring and organic electroluminescent device
06/18/2008EP1932839A1 Indolecarboxylic acid derivative having pgd2 receptor antagonistic activity
06/18/2008EP1932833A1 Nitrogenated heterocyclic compound and pharmaceutical composition comprising the same
06/18/2008EP1931680A1 Indol-3-yl-carbonyl-azaspiro derivatives as vasopressin receptor antagonists
06/18/2008EP1931670A1 Pyridopyrimidinone inhibitors of pi3k
06/18/2008EP1931669A1 Kinase inhibitors
06/18/2008EP1931668A2 Substituted pyrazolo [3,4-b]pyridines as phosphodiesterase inhibitors
06/18/2008EP1931667A1 Pyrido-pyridimidine derivatives useful as antiinflammatory agents
06/18/2008EP1931666A1 Imidazopyridine derivatives as a2b adenosine receptor antagonists
06/18/2008EP1931665A1 1-[[1-[(2-amin0-6-methyl-4-pyridinyl)methyl]-4-flu0r0-4-piperidinyl,]carbonyl]-4-[2-(2-pyridinyl)-3h-imidaz0[4, 5-b]pyridin-3-yl]piperidine useful as histamine h3 antagonist
06/18/2008EP1931664A2 Methods of modulating neurotrophin-mediated activity
06/18/2008EP1931663A1 Imdolizine derivatives as ligands of the crth2 receptor
06/18/2008EP1931656A1 Novel drugs for dementia
06/18/2008EP1931641A2 NOVEL 4-CYANO, 4-AMINO, AND 4-AMINOMETHYL DERIVATIVES OF PYRAZOLO[1,5-a]PYRIDINES, PYRAZOLO[1,5-c]PYRIMIDINES AND 2H-INDAZOLE COMPOUNDS AND 5-CYANO, 5-AMINO, AND 5-AMINOMETHYL DERIVATIVES OF IMIDAZO[1,2-a]PYRIDINES, AND IMIDAZO[1,5-a]PYRAZINES COMPOUNDS AS CYCLIN DEPENDENT KINASE INHI
06/18/2008EP1931631A1 1- (1h- indol- 1-yl) -3- (methylamino) -1- phenylpropan-2-ol derivatives and related compounds as modulators of the monoamine reuptake for the treatment of vasomotor symptoms (vms)
06/18/2008EP1931627A1 Amino-alkyl-amide derivatives as ccr3 receptor ligands
06/18/2008EP1697376B1 Spiro-condensed indoline derivatives as pesticides
06/18/2008EP1675853B1 Imidazo(4,5-b)pyridine-derivatives as inducible no-synthase inhibitors
06/18/2008CN101203518A Novel fluorene derivatives, composition containing said derivatives and the use thereof
06/18/2008CN101203517A 1- ( 2-amino-3- (substituted alkyl)-3h-benzimidazoiylmethyl) -3-subtituted-1,3-dihydro-benzoimidazol-2-ones with activity on respiratory syncytial virus
06/18/2008CN101203516A Purine and imidazopyridine derivatives for immunosuppression
06/18/2008CN101203515A Pyrido[2,3-d]pyrimidines used as HCV inhibitors, and methods for the preparation thereof
06/18/2008CN101203514A Substituted pyrido (2 , 3-d) pyrimidine derivatives useful as medicines for the treatment of autoimmune disorders
06/18/2008CN101200466A Heterocyclic compounds having antithrombotic activity, preparation method and uses thereof
06/17/2008US7388096 Crystalline forms of a factor Xa inhibitor
06/17/2008US7388027 sarcopenia,frailty or age-related functional decline; nonsteroidal, nontoxic; side effect reduction;2-Chloro-4-(7-hydroxy-1-methyl-3-oxo-5,6,7,7a-tetrahydro-3H-pyrrolizin-2-yl)-3-methylbenzonitrile
06/17/2008US7388019 3-amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
06/17/2008US7388016 10,11-dimethoxydibenzo[c,f]-2,7-naphthyridin-6-amine; inhibiting pyruvate dehydrogenase kinase PDK-1in a cell; antiproliferative agent;brain, colon cancer, leukemia, prostate and breast cancer
06/17/2008US7388011 Inhibiting the proteolytic activity of cathepsin S; 4-{3-[5-Acetyl-3-(4-chloro-phenyl)-4,5,6,7-tetrahydro-pyrazolo[4,3-c]pyridin-1-yl]-2-hydroxy-propyl}-3,4,5,6-tetrahydro-2H-[1,2']bipyrazinyl-3'-carbonitrile; antiarthritic agent; autoimmune disease: lupus, rheumatoid arthritis, and asthma
06/17/2008CA2501799C Pyrazole compounds for treatment of neurodegenerative disorders
06/17/2008CA2302347C 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-10-oles, processes for their preparation and their use for medicaments
06/17/2008CA2249446C Irreversible inhibitors of tyrosine kinases
06/17/2008CA2202487C Fused pyrrolocarbazoles
06/12/2008WO2008070507A2 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
06/12/2008WO2008069997A1 Substituted diazepan compounds as orexin receptor antagonists
06/12/2008WO2008068470A1 Antibacterial polycyclic urea compounds
06/12/2008WO2008068392A1 Novel imidazo[1,2-a]pyridine-3-ylamine fluorophore derivatives and process for the preparation thereof
06/12/2008WO2008068265A1 Novel substituted diaza spiro pyridinone derivatives for use in mch-1 mediated diseases
06/12/2008WO2008068185A1 Spiro-piperidine derivatives as via receptor antagonists
06/12/2008WO2008068171A1 Substituted pyrimidines and their use as jnk modulators
06/12/2008WO2008068159A1 Spiro-piperidine derivatives
06/12/2008WO2008045393A3 Imidazo- and triazolo-pyridine compounds and methods of use therof
06/12/2008WO2008031556A3 2 amino-pyrimidine derivatives as h4 receptor antagonists, processes for preparing them and their use in pharmaceutical compositions
06/12/2008WO2008014888A3 Imino-imidazo-pyridine derivatives having antithrombotic activity
06/12/2008WO2008000483A3 Phenol derivatives for the treatment of respiratory diseases
06/12/2008WO2007143523A3 Fused, tricyclic sulfonamide inhibitors of gamma secretase
06/12/2008WO2007081597A3 Peri condensed tricyclic compounds useful as antibacterial agents
06/12/2008US20080139608 2,6,8, Trisubstituted 1-deazapurines and their different uses
06/12/2008US20080139607 Inhibitors of the serine protease PAI-1 (plasminogen activator inhibitor type 1); (3R)-8-(3,4-Difluoro-phenyl)-7-heptyl-5-oxo-2,3-dihydro-5H-thiazolo[3,2-a]pyridine-3-carboxylic acid for example; desulfurization to form corresponding 1-(1-carboxyethyl)-1,2-dihydro-2-oxopyridine compound; coadministering
06/12/2008US20080139606 Substituted Pyrrolopyridines, Compositions Containing Them, Manufacturing Process Therefor and Use Thereof
06/12/2008US20080139605 Substituted prolinamides, manufacturing, and the use thereof as medicaments
06/12/2008US20080139595 Hetaryloxy-Substituted Phenylamino Pyrimidines as Rho Kinase Inhibitors
06/12/2008US20080139594 e.g. 4-[8-Chloro-2-(3-methoxyphenyl)imidazo[1,2-a]pyridin-3-yl]-n-phenylpyrimidin-2-amine; synthesis
06/12/2008US20080139586 Kinesin spindle protein (KSP) inhibitors, e.g., N-(3-amino-2-(R,S)-fluoropropyl)-N-[1-(3-benzyl-4-oxo-3,4-dihydropyrido[3,4-d]pyrimidin-2-yl)-2-(R,S)-methylpropyl]-4-methylbenzamide; antiproliferative and -carcinogenic agents; side effects reduction
06/12/2008US20080139579 Hiv Integrase Inhibitors
06/12/2008US20080139558 Quinolones useful as inducible nitric oxide synthase inhibitors
06/12/2008US20080138656 Heterocyclic compound and organic light-emitting device
06/12/2008US20080138329 Inhibitors of Dna Methylation in Tumor Cells
06/12/2008US20080138287 3-substituted-2(arylalkyl)-1- azabicycloalkanes and methods of use thereof
06/12/2008US20080135833 Configurationally controlled n,n'-dicycloalkyl-substituted naphthalene-based tetracarboxylic diimide compounds as n-type semiconductor materials for thin film transistors
06/12/2008DE102006058236A1 Indolizinderivate Indolizine derivatives
06/12/2008DE102006057612A1 New spiro compounds useful as photo-adjustable catalysts in organic synthesis and as photo-catalysts in the polymerization reaction
06/12/2008CA2671990A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
06/12/2008CA2670892A1 Substituted diazepan compounds as orexin receptor antagonists
06/12/2008CA2670870A1 Antibacterial polycyclic urea compounds
06/12/2008CA2670674A1 Spiro-piperidine derivatives as via receptor antagonists
06/12/2008CA2670671A1 Spiro-piperidine derivatives
06/12/2008CA2670375A1 Substituted pyrimidines and their use as jnk modulators
06/12/2008CA2664112A1 Novel substituted diaza-spiro-pyridinone derivatives for use in mch-1 mediated diseases
06/11/2008EP1930330A1 Pleuromutilin derivatives as antimicrobials
06/11/2008EP1930325A1 Process for producing optically active piperazine compound
06/11/2008EP1930322A1 1-(4-piperidinyl)-1,3-dihydro-2H-benzoxazole-2-one derivatives and related compounds as nociceptin analogs and ORL1 ligands for the treatment of pain
06/11/2008EP1930319A1 Proline derivatives and use thereof as drugs
06/11/2008EP1928887A1 Methods of preparing quinolone analogs
06/11/2008EP1928875A1 2-amino-7,8-dihydro-6h-pyridoý4,3-d¨pyrimidin-5-ones
06/11/2008EP1928874A1 Heterobicyclic compounds as glucokinase activators
06/11/2008EP1928873A1 Dihydroquinophenanthrine dione and tetrahydroquinophenanthrine dione fluorescent whitening agents